HK1026151A1 - Stabilized protein compositions - Google Patents
Stabilized protein compositionsInfo
- Publication number
- HK1026151A1 HK1026151A1 HK00105539A HK00105539A HK1026151A1 HK 1026151 A1 HK1026151 A1 HK 1026151A1 HK 00105539 A HK00105539 A HK 00105539A HK 00105539 A HK00105539 A HK 00105539A HK 1026151 A1 HK1026151 A1 HK 1026151A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein compositions
- stabilized protein
- stabilized
- compositions
- protein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9687698P | 1998-08-17 | 1998-08-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1026151A1 true HK1026151A1 (en) | 2000-12-08 |
Family
ID=22259521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK00105539A HK1026151A1 (en) | 1998-08-17 | 2000-09-04 | Stabilized protein compositions |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050232898A1 (xx) |
EP (1) | EP0988861B1 (xx) |
JP (1) | JP3641170B2 (xx) |
CN (1) | CN1250282C (xx) |
AR (1) | AR016504A1 (xx) |
AT (1) | ATE260674T1 (xx) |
AU (2) | AU767431B2 (xx) |
BR (1) | BR9904150A (xx) |
CA (1) | CA2280449A1 (xx) |
DE (1) | DE69915204T2 (xx) |
DK (1) | DK0988861T3 (xx) |
ES (1) | ES2216447T3 (xx) |
HK (1) | HK1026151A1 (xx) |
NZ (2) | NZ510140A (xx) |
PT (1) | PT988861E (xx) |
TW (1) | TWI221773B (xx) |
ZA (1) | ZA995201B (xx) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2337661A1 (en) | 2000-02-29 | 2001-08-29 | Pfizer Products Inc. | Stabilized granulocyte colony stimulating factor |
US20040156835A1 (en) * | 2001-05-30 | 2004-08-12 | Taiji Imoto | Protein preparation |
ITMI20021684A1 (it) * | 2002-07-29 | 2004-01-29 | Therapicon Srl | Composizione farmaceutica di peptide nasale |
ITBA20020032A1 (it) * | 2002-09-24 | 2004-03-25 | Bio D Soc | Metodo per stabilizzare le proteine per la conservazione ad alte temperature. |
EP1641484A2 (en) * | 2003-05-09 | 2006-04-05 | Schering Aktiengesellschaft | Treatment of inflammatory respiratory diseases |
SI1682184T1 (sl) * | 2003-11-04 | 2014-02-28 | Lek Pharmaceuticals D.D. | Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov |
EP1537876A1 (en) * | 2003-12-01 | 2005-06-08 | BioGeneriX AG | Erythropoietin solution formulation |
WO2005060953A1 (en) * | 2003-12-09 | 2005-07-07 | Alcon, Inc. | Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions |
KR101340354B1 (ko) * | 2004-11-12 | 2013-12-11 | 노보 노르디스크 에이/에스 | 안정한 펩티드 제제 |
EP1787658B1 (en) * | 2005-11-10 | 2012-03-14 | CHEMI S.p.A. | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
DE202006020194U1 (de) * | 2006-03-01 | 2007-12-06 | Bioceuticals Arzneimittel Ag | G-CSF-Flüssigformulierung |
EP2094247B1 (en) | 2006-10-20 | 2022-06-29 | Amgen Inc. | Stable polypeptide formulations |
BRPI0815280A2 (pt) | 2007-08-27 | 2018-11-27 | Biogenerix Ag | medicamento que compreende uma formulação líquida aquosa de g-csf, receptáculo para a administração de medicamentos líquidos, seringa ou ampola, kit para a administração parenteral de g-csf |
PL2197970T3 (pl) * | 2007-10-09 | 2011-10-31 | Hercules Inc | Kompozycje adhezyjne zawierające środek sieciujący |
UA118536C2 (uk) * | 2008-07-23 | 2019-02-11 | Амбркс, Інк. | Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування |
AR083006A1 (es) * | 2010-09-23 | 2013-01-23 | Lilly Co Eli | Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas |
ITMI20120338A1 (it) * | 2012-03-06 | 2013-09-07 | Dr Andrea Bignotti | Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico |
GB2516808A (en) | 2013-05-31 | 2015-02-11 | Innova Biosciences Ltd | Antibody composition and buffer system therefor |
AU2016205456B2 (en) | 2015-01-05 | 2021-10-07 | Cornell University | Compositions and methods using IL-8 to improve milk production and reproductive health in mammals |
US11464831B2 (en) | 2015-01-05 | 2022-10-11 | Cornell University | Compositions and methods using IL-8 for improving health of mammals |
US11291680B2 (en) | 2016-12-15 | 2022-04-05 | Société des Produits Nestlé S.A. | Compositions and methods that modulate white blood cells or neutrophils in a companion animal |
EP3771463A1 (en) | 2019-07-29 | 2021-02-03 | Ludwig-Maximilians-Universität München | Stabilizing therapeutic proteins with piperazin- or morpholine-containing zwitterionic buffering substances |
CN116836920B (zh) * | 2023-08-21 | 2024-05-24 | 广东横琴粤澳深度合作区齐美国际干细胞医院有限公司 | 一种无血清培养基及其制备间充质干细胞的方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3273597D1 (en) * | 1981-11-28 | 1986-11-06 | Sunstar Kk | Pharmaceutical composition containing interferon in stable state |
JPS6069037A (ja) * | 1983-09-26 | 1985-04-19 | Sunstar Inc | エリテマト−デス治療用外用剤 |
US4605555A (en) * | 1984-09-20 | 1986-08-12 | Sun Star Kabushiki Kaisha | Composition and method for treating keratosic disorder of skin and mucosa |
JPH0618781B2 (ja) * | 1986-10-18 | 1994-03-16 | 中外製薬株式会社 | 感染症治療剤 |
EP0347041A3 (en) * | 1988-05-13 | 1990-11-22 | Amgen Inc. | Compositions and method for treating or preventing infections in animals |
US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
US6066469A (en) * | 1990-03-08 | 2000-05-23 | Ferro Dynamics, Inc. | Cloning, expression, and uses of human lactoferrin |
DE4242919A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF |
US5580856A (en) * | 1994-07-15 | 1996-12-03 | Prestrelski; Steven J. | Formulation of a reconstituted protein, and method and kit for the production thereof |
-
1999
- 1999-08-06 DE DE69915204T patent/DE69915204T2/de not_active Expired - Fee Related
- 1999-08-06 AT AT99306262T patent/ATE260674T1/de not_active IP Right Cessation
- 1999-08-06 ES ES99306262T patent/ES2216447T3/es not_active Expired - Lifetime
- 1999-08-06 EP EP99306262A patent/EP0988861B1/en not_active Expired - Lifetime
- 1999-08-06 DK DK99306262T patent/DK0988861T3/da active
- 1999-08-06 PT PT99306262T patent/PT988861E/pt unknown
- 1999-08-11 TW TW088113760A patent/TWI221773B/zh not_active IP Right Cessation
- 1999-08-13 AR ARP990104080A patent/AR016504A1/es active IP Right Grant
- 1999-08-13 CA CA002280449A patent/CA2280449A1/en not_active Abandoned
- 1999-08-16 AU AU44501/99A patent/AU767431B2/en not_active Ceased
- 1999-08-16 NZ NZ510140A patent/NZ510140A/en unknown
- 1999-08-16 NZ NZ337258A patent/NZ337258A/en unknown
- 1999-08-16 ZA ZA9905201A patent/ZA995201B/xx unknown
- 1999-08-17 BR BR9904150-2A patent/BR9904150A/pt not_active Application Discontinuation
- 1999-08-17 CN CNB99122020XA patent/CN1250282C/zh not_active Expired - Fee Related
- 1999-08-17 JP JP23085399A patent/JP3641170B2/ja not_active Expired - Fee Related
-
2000
- 2000-09-04 HK HK00105539A patent/HK1026151A1/xx not_active IP Right Cessation
-
2004
- 2004-02-13 AU AU2004200568A patent/AU2004200568A1/en not_active Abandoned
-
2005
- 2005-06-01 US US11/143,340 patent/US20050232898A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0988861A1 (en) | 2000-03-29 |
AU2004200568A1 (en) | 2004-03-11 |
JP3641170B2 (ja) | 2005-04-20 |
ATE260674T1 (de) | 2004-03-15 |
NZ337258A (en) | 2001-04-27 |
DE69915204D1 (de) | 2004-04-08 |
CN1250668A (zh) | 2000-04-19 |
BR9904150A (pt) | 2000-12-26 |
TWI221773B (en) | 2004-10-11 |
ZA995201B (en) | 2001-02-16 |
CA2280449A1 (en) | 2000-02-17 |
PT988861E (pt) | 2004-06-30 |
NZ510140A (en) | 2005-01-28 |
DK0988861T3 (da) | 2004-04-19 |
CN1250282C (zh) | 2006-04-12 |
ES2216447T3 (es) | 2004-10-16 |
JP2000063264A (ja) | 2000-02-29 |
AU4450199A (en) | 2000-03-09 |
AR016504A1 (es) | 2001-07-04 |
EP0988861B1 (en) | 2004-03-03 |
AU767431B2 (en) | 2003-11-13 |
US20050232898A1 (en) | 2005-10-20 |
DE69915204T2 (de) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1113799A4 (en) | PROTEIN-BASED PREPARATION | |
AP2000001874A0 (en) | Cellecoxib compositions | |
GB9917982D0 (en) | Compositions | |
GB9811377D0 (en) | Compositions | |
HK1026151A1 (en) | Stabilized protein compositions | |
GB9924268D0 (en) | Compositions | |
GB9828861D0 (en) | Compositions | |
IL139873A0 (en) | Angoistatin-binding protein | |
GB2339693B (en) | Anti-mollusc compositions | |
GB9805782D0 (en) | Compositions | |
GB9812818D0 (en) | Dentfrice compositions | |
GB9827291D0 (en) | Compositions | |
GB9806810D0 (en) | Compositions | |
GB9822158D0 (en) | Compositions | |
GB2336535B (en) | Compositions | |
GB9828880D0 (en) | Protein | |
GB9809347D0 (en) | Compositions | |
GB9827690D0 (en) | Compositions | |
GB9816050D0 (en) | Compositions | |
GB9819038D0 (en) | Protein | |
GB9812607D0 (en) | Protein | |
GB9809566D0 (en) | Protein | |
GB9818278D0 (en) | Compositions | |
GB9816096D0 (en) | Protein | |
GB9823975D0 (en) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100817 |